Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,526,452
New position
Shares Held
9,740
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#500
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $56,648,218 across 9 Drug Manufacturers - General names. NVS ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,449 | $30,524,296 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
128,157 | $7,384,406 | |
| 3 | BIIB |
Biogen Inc.
|
20,649 | $4,461,422 | |
| 4 | PFE |
Pfizer Inc
|
173,689 | $4,182,431 | |
| 5 | AMGN |
Amgen Inc
|
8,927 | $3,232,645 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,216 | $2,933,109 | |
| 7 | NVS |
Novartis AG
This page
|
9,740 | $1,526,452 | |
| 8 | AZN |
Astrazeneca PLC
|
7,754 | $1,470,313 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,526,452 | 9,740 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||